Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash from Financing Activities (2021 - 2025)

P3 Health Partners (PIII) has disclosed Cash from Financing Activities for 5 consecutive years, with $14.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities rose 689.94% year-over-year to $14.7 million, compared with a TTM value of $93.7 million through Sep 2025, up 18.32%, and an annual FY2024 reading of $98.8 million, down 1.56% over the prior year.
  • Cash from Financing Activities was $14.7 million for Q3 2025 at P3 Health Partners, roughly flat from $14.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $56.1 million in Q2 2024 and bottomed at -$2.5 million in Q3 2024.
  • Average Cash from Financing Activities over 5 years is $13.1 million, with a median of $12.4 million recorded in 2021.
  • The sharpest move saw Cash from Financing Activities tumbled 5331.07% in 2022, then soared 1268.35% in 2023.
  • Year by year, Cash from Financing Activities stood at $12.3 million in 2021, then rose by 21.97% to $15.0 million in 2022, then dropped by 5.99% to $14.1 million in 2023, then soared by 139.09% to $33.7 million in 2024, then crashed by 56.5% to $14.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for PIII at $14.7 million in Q3 2025, $14.6 million in Q2 2025, and $30.7 million in Q1 2025.